13F-HR filed by Vestal Point Capital, LP
Vestal Point Capital, LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-14, with 58 holding rows worth $1,209,215,773.
- Accession
- 0001974915-24-000005
- Filer
- CIK 1974915
- Filed
- 2024-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 58 entries on the cover page, a total value of $1,209,215,773 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,209,215,773 with VALUE read as dollars as filed, 13F file number 028-23784. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,150,000 | $150,736,500 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 1,100,000 | $132,462,000 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 710,000 | $97,923,200 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 525,000 | $79,364,250 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 1,000,000 | $53,640,000 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 1,250,000 | $53,500,000 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 350,000 | $52,307,500 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 325,000 | $50,826,750 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 800,000 | $38,384,000 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 5,110,000 | $34,748,000 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 2,000,000 | $29,500,000 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 2,610,000 | $29,101,500 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 400,000 | $27,100,000 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 4,725,000 | $24,570,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 750,000 | $20,347,500 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 50,000 | $19,686,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 400,000 | $17,220,000 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 1,050,000 | $15,970,500 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,100,000 | $15,482,500 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 175,000 | $15,284,500 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 350,000 | $13,874,000 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 1,035,000 | $13,786,200 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 455,000 | $13,650,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 225,000 | $13,225,500 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 100,000 | $12,946,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 210,000 | $12,814,200 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 1,200,000 | $12,612,000 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 200,000 | $11,394,000 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 725,000 | $10,672,000 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 325,000 | $9,503,000 | dollars as filed | |
| SHOCKWAVE MED INC | 82489T104 | COM | 25,000 | $8,140,750 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 45,000 | $8,006,850 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 655,000 | $7,768,300 | dollars as filed | |
| GERON CORP | 374163103 | COM | 2,200,000 | $7,260,000 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 100,000 | $6,955,000 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 100,000 | $6,906,000 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 695,000 | $6,560,800 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 75,000 | $6,150,000 | dollars as filed | |
| PASSAGE BIO INC | 702712100 | COM | 4,500,000 | $6,075,000 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 1,350,000 | $6,034,500 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 800,000 | $5,872,000 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 600,000 | $5,586,000 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 1,200,000 | $5,580,000 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 15,000 | $5,188,050 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 110,000 | $5,135,900 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 800,000 | $4,976,000 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 130,000 | $4,186,000 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 250,000 | $3,837,500 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 175,000 | $2,744,000 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 360,000 | $2,520,000 | dollars as filed | |
| NOVAVAX INC | 670002401 | COM NEW | 500,000 | $2,390,000 | dollars as filed | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 80,000 | $2,337,600 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 2,800,000 | $1,943,200 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 1,500,000 | $1,875,000 | dollars as filed | |
| CHIMERIX INC COM | 16934W106 | Stock | 1,400,000 | $1,484,000 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 295,375 | $490,323 | dollars as filed | |
| AFFIMED N V | N01045207 | COM | 55,000 | $291,500 | dollars as filed | |
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 130,000 | $289,900 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001974915-24-000005 | this filing | 2024-05-14 | acceptance time not in the bulk data set |